Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression
- PMID: 34425488
- PMCID: PMC8376475
- DOI: 10.1016/j.jpsychires.2021.08.031
Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression
Abstract
Aim: Delirium is a common presenting symptom among older patients. Patients who presented with delirium may have a higher morbidity and mortality rate due to older age, other comorbidities, and atypical COVID-19 presentation. Currently, the evidence supporting delirium as one of the predictors of poor outcome of COVID-19 is still insufficient. This study aims to explore the potential association between delirium and poor outcomes from COVID-19.
Methods: We systematically searched the PubMed and Google Scholar databases using specific keywords related to our aims until January 30th, 2021. All articles published on COVID-19 and delirium were retrieved. The quality of the study was assessed using the Newcastle Ottawa Scale (NOS) tool for observational studies and Joanna Briggs Institute (JBI) Critical Appraisal Tools for case-series studies. Statistical analysis was done using Review Manager 5.4 software.
Results: Our meta-analysis of 20 studies showed that delirium symptoms on admission was associated with poor outcomes from COVID-19 [OR 2.36 (95% CI 1.80-3.09), p < 0.00001, I2 = 76%, random-effect models] and its subgroup which consist of severe COVID-19 [OR 3.89 (95% CI 1.72-8.75), p = 0.001, I2 = 91%, random-effect models], and mortality from COVID-19 [OR 1.90 (95% CI 1.55-2.33), p < 0.00001, I2 = 36%, random-effect models]. Meta-regression showed that the association was influenced by age (p = 0.005).
Conclusions: Our study suggests delirium as an important marker to identify patients at higher risk for developing poor COVID-19 outcomes. The physicians should add delirium as one of the common presenting symptoms of COVID-19 in older populations.
Keywords: COVID-19; Confusion; Coronavirus disease 2019; Delirium; Neurologic symptoms.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.Parkinsonism Relat Disord. 2021 Jun;87:155-161. doi: 10.1016/j.parkreldis.2021.04.019. Epub 2021 Apr 24. Parkinsonism Relat Disord. 2021. PMID: 33931304 Free PMC article.
-
Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis.Arch Gerontol Geriatr. 2021 Mar-Apr;93:104299. doi: 10.1016/j.archger.2020.104299. Epub 2020 Nov 19. Arch Gerontol Geriatr. 2021. PMID: 33285424 Free PMC article.
-
Risk factors and outcomes of delirium in hospitalized older adults with COVID-19: A systematic review and meta-analysis.Aging Health Res. 2023 Mar;3(1):100125. doi: 10.1016/j.ahr.2023.100125. Epub 2023 Feb 3. Aging Health Res. 2023. PMID: 36778764 Free PMC article. Review.
-
Delirium and Mortality in Coronavirus Disease 2019 (COVID-19) - A Systematic Review and Meta-analysis.Arch Gerontol Geriatr. 2021 Jul-Aug;95:104388. doi: 10.1016/j.archger.2021.104388. Epub 2021 Mar 5. Arch Gerontol Geriatr. 2021. PMID: 33713880 Free PMC article.
-
Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis.Neurology. 2021 Dec 7;97(23):e2269-e2281. doi: 10.1212/WNL.0000000000012930. Epub 2021 Oct 11. Neurology. 2021. PMID: 34635561 Free PMC article.
Cited by
-
Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression.Diabetes Res Clin Pract. 2023 Jan;195:110205. doi: 10.1016/j.diabres.2022.110205. Epub 2022 Dec 9. Diabetes Res Clin Pract. 2023. PMID: 36502891 Free PMC article.
-
Pregnancy and neurologic complications of COVID-19: A scoping review.Acta Neurol Scand. 2022 Jul;146(1):6-23. doi: 10.1111/ane.13621. Epub 2022 Apr 7. Acta Neurol Scand. 2022. PMID: 35388457 Free PMC article.
-
Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression.Gen Hosp Psychiatry. 2022 Mar-Apr;75:61-67. doi: 10.1016/j.genhosppsych.2022.01.010. Epub 2022 Feb 4. Gen Hosp Psychiatry. 2022. PMID: 35182908 Free PMC article.
-
Symptom Management and Support in Dying Patients with Cancer and Coronavirus Disease-19-A Register-Based Study.J Palliat Care. 2023 Jul;38(3):261-267. doi: 10.1177/08258597231157622. Epub 2023 Feb 15. J Palliat Care. 2023. PMID: 36793233 Free PMC article.
-
Coronavirus Disease-2019 in Older People with Cognitive Impairment.Clin Geriatr Med. 2022 Aug;38(3):501-517. doi: 10.1016/j.cger.2022.03.002. Epub 2022 Mar 21. Clin Geriatr Med. 2022. PMID: 35868669 Free PMC article. Review.
References
-
- Aiello A., Farzaneh F., Candore G., Caruso C., Davinelli S., Gambino C.M., et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front. Immunol. 2019 Sep 25;10:2247. doi: 10.3389/fimmu.2019.02247. - DOI - PMC - PubMed
-
- Bellelli G., Nobili A., Annoni G., Morandi A., Djade C.D., Meagher D.J., et al. Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards. Eur. J. Intern. Med. 2015 Nov;26(9):696–704. doi: 10.1016/j.ejim.2015.08.006. - DOI - PubMed
-
- Cheng A., Hu L., Wang Y., Huang L., Zhao L., Zhang C., et al. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients. Int. J. Antimicrob. Agents. 2020 Sep;56(3):106110. doi: 10.1016/j.ijantimicag.2020.106110. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical